Ursodiol does not prevent hepatic venoocclusive disease associated with Mylotarg therapy.

haematologica vol. 87(10):october 2002 *University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; °Tarbiat Modarres University, School of Medical Sciences, Tehran, Iran; #Department of Clinical Chemistry, Municipal Hospital Rudolfstiftung, Vienna, Austria; @ViennaLab Labordiagnostika GmbH, Vienna, Austria Acknowledgments: we wish to thank A. Moritz, A. Tabarroki, E. Mehdipour, P. Vosough, M. Alebouyeh, Y. Shafaghati, A. HadgFathali, F. Mojtahedzadeh, T. Arzanian, and F. Khoshaiin for their support, and M.H. Karimi-Nejad and D. Farhoud for their assistance in collecting the subjects for this study. Funding: this work was supported by a grant from the Iranian Ministry of Health and Medical Education, Deputy of Research and Technology (contract grant no. 11059). Correspondence: Dr. Hossein Najmabadi, MD, Ph.D., Genetics Research Center, The Social Welfare and Rehabilitation Sciences University, Daneshjoo Blvd., Koodakyar Ave., Evin, Tehran 19834, Iran. Phone/fax: international +98.21.2407814. E-mail: [email protected]